Neuberger Berman Group LLC boosted its holdings in Envision Healthcare Corporation (NYSE:EVHC) by 173.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 579,593 shares of the company’s stock after buying an additional 367,788 shares during the quarter. Neuberger Berman Group LLC owned approximately 0.49% of Envision Healthcare Corporation worth $36,323,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of EVHC. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in Envision Healthcare Corporation during the 1st quarter valued at approximately $135,000. Korea Investment CORP acquired a new stake in Envision Healthcare Corporation during the 1st quarter valued at approximately $141,000. Ameritas Investment Partners Inc. acquired a new stake in Envision Healthcare Corporation during the 1st quarter valued at approximately $172,000. First Interstate Bank acquired a new stake in Envision Healthcare Corporation during the 1st quarter valued at approximately $184,000. Finally, Daiwa Securities Group Inc. increased its position in Envision Healthcare Corporation by 60.9% during the 1st quarter. Daiwa Securities Group Inc. now owns 3,169 shares of the company’s stock valued at $194,000 after purchasing an additional 1,200 shares during the period. Institutional investors and hedge funds own 64.75% of the company’s stock.

In other news, insider Robert Jon Coward sold 1,500 shares of the business’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $62.69, for a total transaction of $94,035.00. Following the transaction, the insider now directly owns 97,863 shares of the company’s stock, valued at $6,135,031.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 3.10% of the stock is currently owned by insiders.

A number of analysts have weighed in on the stock. Cantor Fitzgerald reissued a “buy” rating on shares of Envision Healthcare Corporation in a research report on Monday, July 24th. Royal Bank Of Canada increased their target price on shares of Envision Healthcare Corporation from $72.00 to $77.00 and gave the company an “outperform” rating in a research report on Tuesday, June 27th. Zacks Investment Research raised shares of Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 target price for the company in a research report on Tuesday, July 4th. BidaskClub raised shares of Envision Healthcare Corporation from a “sell” rating to a “hold” rating in a research report on Saturday, June 17th. Finally, Mizuho decreased their target price on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a “neutral” rating for the company in a research report on Wednesday, August 9th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $71.56.

COPYRIGHT VIOLATION NOTICE: “Neuberger Berman Group LLC Raises Position in Envision Healthcare Corporation (EVHC)” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/09/04/neuberger-berman-group-llc-raises-position-in-envision-healthcare-corporation-evhc.html.

Shares of Envision Healthcare Corporation (NYSE:EVHC) opened at 52.31 on Monday. The firm’s market cap is $6.12 billion. The stock’s 50 day moving average is $54.99 and its 200 day moving average is $59.22. Envision Healthcare Corporation has a 12 month low of $49.56 and a 12 month high of $74.75.

Envision Healthcare Corporation (NYSE:EVHC) last posted its earnings results on Monday, August 7th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.75 by $0.04. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.96 billion. During the same period in the previous year, the firm earned $0.34 earnings per share. The business’s revenue was up 156.7% compared to the same quarter last year. Equities research analysts expect that Envision Healthcare Corporation will post $1.40 EPS for the current year.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Institutional Ownership by Quarter for Envision Healthcare Corporation (NYSE:EVHC)

Receive News & Stock Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related stocks with our FREE daily email newsletter.